Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Comparisons of demographic, clinical, and comprehensive geriatric assessment characteristics between patients with and without pneumoniaPneumonia group (n = 50)Without pneumonia (n = 357) p Age, years73.4 ± 6.772.4 ± 5.90.25Sex, female31(62.0)225(63.0)0.888BMI kg/m 228.2 ± 7.129.4 ± 7.20.281BMI (≥ 30)16(34.8)149(44.5)0.213Education (> 8 years)9(19.1)91(26.3)0.489Smoking history14(30.4)97(28.2)0.752Marital status, married32(68.1)205(59.2)0.245Chronic conditions COPD16(32.0)29(8.2) < 0.001 Hypertension38(76.0)260(73.0)0.657 Coronary artery disease14(28.0)100(28.2)0.980 Diabetes mellitus31(62)143(40.1) 0.003 Malignancy7(14.0)45(12.6)0.788 Chronic kidney disease7(14.0)25(7.1)0.096 Multimorbidity (≥ 2 chronic diseases)40(81.6)277(79.4)0.713 Polypharmacy (≥ 5 drugs)27(56.3)183(52.0)0.579Comprehensive geriatric assessment Katz ADL6.0[0.0]6.0[0.0]0.61 Lawton-Brody IADL8.0[2.0]8.0[1.0]0.60 Clinical frailty scale score4.0[1.0]3.0[1.0]0.76 MNA-SF score13[2.0]14.0[2.0]0.78 Living with frailty (CFS ≥ 4)26(55.3)191(55.5)0.98 Malnutrition (MNA-SF ≤ 11)11(23.4)96(28.1)0.50 Probable sarcopenia21(53.8)129(45.1)0.30 Handgrip strength, kg19 [11.6]21.0 [11.1]0.44 4 m walking, sec4.4 ± 2.14.4 ± 2.00.90 TUG test, sec12.7 ± 6.611.4 ± 4.40.30 Chair stand test, sec16.0 ± 9.315.2 ± 5.20.19 YGDS2.0 [4.0]2.0 [4.0]0.82 SMMSE27.0 [4.0]28.0 [5.0]0.67Laboratory parameters Fasting blood glucose, mg/dL111.0 ± 32.0104.0 ± 30.00.071 Creatinine, mg/dL0.8 ± 0.30.8 ± 0.40.241 Magnesium, mg/dL1.9 ± 0.52.0 ± 0.30.155 Leukocyte, ×10³/µL6.3 ± 2.46.9 ± 2.70.846 Neutrophil, ×10³/µL3.7 ± 1.84.1 ± 1.90.883 Lymphocyte, ×10³/µL1.8 ± 1.01.9 ± 0.90.373 HbA1c, %6.1 ± 1.26.2 ± 1.30.155 25-OH-Vitamin D, ng/mL21.0 ± 16.020.0 ± 16.00.815 C-reactive protein, mg/L0.3 ± 1.00.4 ± 0.60.672 Sedimentation rate, mm/h12.0 ± 12.014.0 ± 17.00.434Variables are presented as n (%), mean ± SD, median [IQR] values and bold values indicate statistical significance (p < 0.05)ADL Activities of daily living, COPD Chronic obstructive pulmonary disease, MNA-SF Mini-nutritional assessment short-form, SMMSE Standardized mini-mental state examination, TUG Timed-up-and-go, YGDS The yesavage geriatric depression scale

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This retrospective, single-centre analysis recruited 407 participants aged over 65 years, who presented at the Geriatric Medicine Clinics of Hacettepe University Faculty of Medicine Adult Hospital between December 2021 and December 2022.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of frailty and malnutrition with pneumonia severity in PCV-13 vaccinated older adults: a single-centre experience

Study design awaiting verification · BMC Geriatrics · 2025

Original publication title

Association of frailty and malnutrition with pneumonia severity in PCV-13 vaccinated older adults: a single-centre experience

Yasemin Polat Özer; Zeynep Şahiner; Merve Güner; Kerim Çayıröz; Emir Lütfü Kılıç; Cafer Balcı; Mertcan Uzun; Burcu Balam Doğu; Mustafa Cankurtaran; Ahmet Çağkan İnkaya; Serhat Ünal; Meltem Gülhan Halil

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The findings of this study indicate that malnutrition and frailty are independent risk factors for severe pneumonia diagnosed within a year of PCV13 vaccination in older adults. Consequently, comprehensive geriatric assessment and targeted interventions beyond vaccination are essential to reduce pneumonia risk in frail or malnourished older populations.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Pneumonia remains a leading cause of morbidity and mortality in older adults, particularly due to the age-related decline in immune function. The aim of this study was to evaluate the association between frailty, malnutrition, and the severity of pneumonia in older adults who received the 13-valent pneumococcal conjugate vaccine (PCV13).

Source: Background

Abstract: What methods does the paper describe?

A retrospective analysis was made of 407 geriatric outpatients aged over 65 years who had received PCV13. Clinical and radiological data were collected from electronic health records and verified via telephone interviews. The primary outcomes were incidence and severity of pneumonia (mild vs. severe), hospitalization, mortality, and antibiotic use within one year following vaccination. Pneumonia severity was classified according to established criteria in the literature.

Source: Methods

Abstract: Results

Of the 407 patients evaluated (mean age 73.3 ± 6.3 years; range 65 to 91 years; 62.9% female), 50 (12.2%) developed pneumonia within one year after PCV13 vaccination. Pneumonia was more common in patients with diabetes mellitus (p = 0.003) and chronic obstructive pulmonary disease (p < 0.001). Severe pneumonia was significantly more prevalent among frail individuals (p = 0.006). Compared to patients with mild pneumonia, those with severe pneumonia had higher Clinical Frailty Scale scores and prolonged chair stand test durations (p = 0.002 and p = 0.031, respectively).

After adjusting for age, sex, and frailty, malnutrition emerged as an independent risk factor for severe pneumonia (OR: 11.9, 95% CI: 1.592 to 89.285, p = 0.016).

Source: Results

Abstract: Conclusion

The findings of this study indicate that malnutrition and frailty are independent risk factors for severe pneumonia diagnosed within a year of PCV13 vaccination in older adults. Consequently, comprehensive geriatric assessment and targeted interventions beyond vaccination are essential to reduce pneumonia risk in frail or malnourished older populations.

Source: Conclusion
Authors’ abstract

Background

Pneumonia remains a leading cause of morbidity and mortality in older adults, particularly due to the age-related decline in immune function. The aim of this study was to evaluate the association between frailty, malnutrition, and the severity of pneumonia in older adults who received the 13-valent pneumococcal conjugate vaccine (PCV13).

Methods

A retrospective analysis was made of 407 geriatric outpatients aged over 65 years who had received PCV13. Clinical and radiological data were collected from electronic health records and verified via telephone interviews. The primary outcomes were incidence and severity of pneumonia (mild vs. severe), hospitalization, mortality, and antibiotic use within one year following vaccination. Pneumonia severity was classified according to established criteria in the literature.

Results

Of the 407 patients evaluated (mean age 73.3 ± 6.3 years; range 65 to 91 years; 62.9% female), 50 (12.2%) developed pneumonia within one year after PCV13 vaccination. Pneumonia was more common in patients with diabetes mellitus (p = 0.003) and chronic obstructive pulmonary disease (p < 0.001). Severe pneumonia was significantly more prevalent among frail individuals (p = 0.006). Compared to patients with mild pneumonia, those with severe pneumonia had higher Clinical Frailty Scale scores and prolonged chair stand test durations (p = 0.002 and p = 0.031, respectively).

After adjusting for age, sex, and frailty, malnutrition emerged as an independent risk factor for severe pneumonia (OR: 11.9, 95% CI: 1.592 to 89.285, p = 0.016).

Conclusion

The findings of this study indicate that malnutrition and frailty are independent risk factors for severe pneumonia diagnosed within a year of PCV13 vaccination in older adults. Consequently, comprehensive geriatric assessment and targeted interventions beyond vaccination are essential to reduce pneumonia risk in frail or malnourished older populations.

Trial registration

Not applicable.

Publication and source details

Original title: Association of frailty and malnutrition with pneumonia severity in PCV-13 vaccinated older adults: a single-centre experience

Yasemin Polat Özer; Zeynep Şahiner; Merve Güner; Kerim Çayıröz; Emir Lütfü Kılıç; Cafer Balcı; Mertcan Uzun; Burcu Balam Doğu; Mustafa Cankurtaran; Ahmet Çağkan İnkaya; Serhat Ünal; Meltem Gülhan Halil

BMC Geriatrics · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:06:37.274408+00:00

DOI: 10.1186/s12877-025-06736-5 · PMC12822101